

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * heme biosynthetic process (GO:0006783) | 9.81301969 |
| 2 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 9.58345389 |
| 3 | N-acetylneuraminate metabolic process (GO:0006054) | 9.03006137 |
| 4 | centriole replication (GO:0007099) | 8.74941976 |
| 5 | * tetrapyrrole biosynthetic process (GO:0033014) | 8.70616150 |
| 6 | base-excision repair, AP site formation (GO:0006285) | 8.08311371 |
| 7 | * heme metabolic process (GO:0042168) | 7.91049221 |
| 8 | positive regulation of histone deacetylation (GO:0031065) | 7.78167329 |
| 9 | * porphyrin-containing compound metabolic process (GO:0006778) | 7.73645078 |
| 10 | cellular extravasation (GO:0045123) | 7.29908180 |
| 11 | centriole assembly (GO:0098534) | 7.23927320 |
| 12 | erythrocyte maturation (GO:0043249) | 7.21077835 |
| 13 | purine deoxyribonucleotide catabolic process (GO:0009155) | 7.09328636 |
| 14 | regulation of MHC class II biosynthetic process (GO:0045346) | 6.41807654 |
| 15 | axonemal dynein complex assembly (GO:0070286) | 6.25579577 |
| 16 | amino sugar catabolic process (GO:0046348) | 6.10338499 |
| 17 | epithelial cilium movement (GO:0003351) | 6.07292141 |
| 18 | erythrocyte development (GO:0048821) | 5.98216803 |
| 19 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.93171149 |
| 20 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.93171149 |
| 21 | cilium movement (GO:0003341) | 5.80764870 |
| 22 | N-acetylglucosamine metabolic process (GO:0006044) | 5.65564551 |
| 23 | positive regulation of protein deacetylation (GO:0090312) | 5.64474190 |
| 24 | reactive oxygen species biosynthetic process (GO:1903409) | 5.58279156 |
| 25 | regulation of chemokine biosynthetic process (GO:0045073) | 5.49104555 |
| 26 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.48750688 |
| 27 | response to methylmercury (GO:0051597) | 5.32456720 |
| 28 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 5.30588920 |
| 29 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.29766307 |
| 30 | response to lead ion (GO:0010288) | 5.15785478 |
| 31 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.14502869 |
| 32 | * tetrapyrrole metabolic process (GO:0033013) | 5.10578714 |
| 33 | hemoglobin metabolic process (GO:0020027) | 4.98077472 |
| 34 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.97176189 |
| 35 | regulation of growth of symbiont in host (GO:0044126) | 4.97176189 |
| 36 | negative regulation of growth of symbiont in host (GO:0044130) | 4.97176189 |
| 37 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.97176189 |
| 38 | thalamus development (GO:0021794) | 4.93151142 |
| 39 | microglial cell activation (GO:0001774) | 4.91942706 |
| 40 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.74159952 |
| 41 | purine deoxyribonucleotide metabolic process (GO:0009151) | 4.71353213 |
| 42 | viral transcription (GO:0019083) | 4.67943248 |
| 43 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.66303548 |
| 44 | deoxyribonucleotide catabolic process (GO:0009264) | 4.65951703 |
| 45 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.63141116 |
| 46 | ribosomal small subunit assembly (GO:0000028) | 4.62652090 |
| 47 | embryonic hemopoiesis (GO:0035162) | 4.52018117 |
| 48 | one-carbon compound transport (GO:0019755) | 4.51803020 |
| 49 | response to misfolded protein (GO:0051788) | 4.49946355 |
| 50 | response to insecticide (GO:0017085) | 4.46763890 |
| 51 | negative regulation of interleukin-2 production (GO:0032703) | 4.46242662 |
| 52 | erythrocyte differentiation (GO:0030218) | 4.45745779 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 4.45655064 |
| 54 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 4.45540234 |
| 55 | macrophage chemotaxis (GO:0048246) | 4.45312547 |
| 56 | neutrophil mediated immunity (GO:0002446) | 4.39849839 |
| 57 | deoxyribose phosphate catabolic process (GO:0046386) | 4.39003142 |
| 58 | * pigment biosynthetic process (GO:0046148) | 4.33845853 |
| 59 | chaperone-mediated protein transport (GO:0072321) | 4.32393806 |
| 60 | translational termination (GO:0006415) | 4.29900328 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.26856881 |
| 62 | cytokinetic process (GO:0032506) | 4.24823530 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.20594614 |
| 64 | ventricular system development (GO:0021591) | 4.11272906 |
| 65 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.10111685 |
| 66 | myeloid cell development (GO:0061515) | 4.04479787 |
| 67 | cotranslational protein targeting to membrane (GO:0006613) | 4.04294037 |
| 68 | regulation of histone deacetylation (GO:0031063) | 4.02666495 |
| 69 | motile cilium assembly (GO:0044458) | 4.00632411 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 4.00239482 |
| 71 | protein targeting to ER (GO:0045047) | 3.99898702 |
| 72 | axoneme assembly (GO:0035082) | 3.91562676 |
| 73 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.80185334 |
| 74 | * pigment metabolic process (GO:0042440) | 3.77149562 |
| 75 | translational elongation (GO:0006414) | 3.72645210 |
| 76 | protein localization to endoplasmic reticulum (GO:0070972) | 3.69397550 |
| 77 | response to oxygen radical (GO:0000305) | 3.63997593 |
| 78 | removal of superoxide radicals (GO:0019430) | 3.60867456 |
| 79 | cellular response to superoxide (GO:0071451) | 3.60867456 |
| 80 | cellular response to oxygen radical (GO:0071450) | 3.60867456 |
| 81 | behavioral response to nicotine (GO:0035095) | 3.60411079 |
| 82 | defense response to fungus (GO:0050832) | 3.60334985 |
| 83 | regulation of helicase activity (GO:0051095) | 3.59617233 |
| 84 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.55309102 |
| 85 | regulation of erythrocyte differentiation (GO:0045646) | 3.55051883 |
| 86 | hydrogen peroxide catabolic process (GO:0042744) | 3.55010816 |
| 87 | somatic diversification of immunoglobulins (GO:0016445) | 3.54102123 |
| 88 | UV protection (GO:0009650) | 3.50500444 |
| 89 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.50047288 |
| 90 | granulocyte differentiation (GO:0030851) | 3.46578581 |
| 91 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.43660233 |
| 92 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.43660233 |
| 93 | isotype switching (GO:0045190) | 3.43660233 |
| 94 | protein-lipid complex assembly (GO:0065005) | 3.34348999 |
| 95 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.33024161 |
| 96 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.32803806 |
| 97 | cellular protein complex disassembly (GO:0043624) | 3.31017079 |
| 98 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.30084592 |
| 99 | viral life cycle (GO:0019058) | 3.29448857 |
| 100 | glucosamine-containing compound metabolic process (GO:1901071) | 3.27518287 |
| 101 | microtubule depolymerization (GO:0007019) | 3.27319503 |
| 102 | regulation of fatty acid transport (GO:2000191) | 3.26816831 |
| 103 | killing of cells of other organism (GO:0031640) | 3.26608530 |
| 104 | disruption of cells of other organism (GO:0044364) | 3.26608530 |
| 105 | DNA deamination (GO:0045006) | 3.24502499 |
| 106 | induction of positive chemotaxis (GO:0050930) | 3.23393375 |
| 107 | purine-containing compound salvage (GO:0043101) | 3.22765575 |
| 108 | cellular response to cadmium ion (GO:0071276) | 3.20857049 |
| 109 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.19305683 |
| 110 | deoxyribose phosphate metabolic process (GO:0019692) | 3.18885635 |
| 111 | gas transport (GO:0015669) | 3.18666780 |
| 112 | myeloid leukocyte mediated immunity (GO:0002444) | 3.13172686 |
| 113 | DNA strand elongation (GO:0022616) | 3.13028850 |
| 114 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.12254389 |
| 115 | positive regulation of granulocyte differentiation (GO:0030854) | 3.11624149 |
| 116 | megakaryocyte development (GO:0035855) | 3.10567487 |
| 117 | * cofactor biosynthetic process (GO:0051188) | 3.10008524 |
| 118 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 3.09136562 |
| 119 | mitotic recombination (GO:0006312) | 3.06306307 |
| 120 | ribosomal small subunit biogenesis (GO:0042274) | 3.06198252 |
| 121 | platelet formation (GO:0030220) | 3.06141892 |
| 122 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.05819326 |
| 123 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03836613 |
| 124 | protein complex disassembly (GO:0043241) | 3.03115868 |
| 125 | positive regulation of B cell differentiation (GO:0045579) | 3.02172520 |
| 126 | protein autoprocessing (GO:0016540) | 2.98425263 |
| 127 | regulation of cilium movement (GO:0003352) | 2.98021846 |
| 128 | protein deneddylation (GO:0000338) | 2.96573705 |
| 129 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.95532317 |
| 130 | regulation of synapse structural plasticity (GO:0051823) | 2.94606816 |
| 131 | ncRNA 3-end processing (GO:0043628) | 2.92850817 |
| 132 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.92180459 |
| 133 | response to superoxide (GO:0000303) | 2.92153947 |
| 134 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.91200177 |
| 135 | multicellular organismal aging (GO:0010259) | 2.91147416 |
| 136 | oxygen transport (GO:0015671) | 2.87828792 |
| 137 | definitive hemopoiesis (GO:0060216) | 2.87817185 |
| 138 | heme transport (GO:0015886) | 2.87634589 |
| 139 | primary alcohol catabolic process (GO:0034310) | 2.87563791 |
| 140 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.87157817 |
| 141 | telomere maintenance via recombination (GO:0000722) | 2.85691009 |
| 142 | macromolecular complex disassembly (GO:0032984) | 2.82746568 |
| 143 | negative regulation of RNA splicing (GO:0033119) | 2.82697207 |
| 144 | negative regulation of telomere maintenance (GO:0032205) | 2.81936049 |
| 145 | DNA replication checkpoint (GO:0000076) | 2.81914525 |
| 146 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81546808 |
| 147 | protein-cofactor linkage (GO:0018065) | 2.81079831 |
| 148 | angiotensin maturation (GO:0002003) | 2.80851023 |
| 149 | translational initiation (GO:0006413) | 2.79699148 |
| 150 | left/right pattern formation (GO:0060972) | 2.79664296 |
| 151 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79035896 |
| 152 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79035896 |
| 153 | negative regulation of viral entry into host cell (GO:0046597) | 2.79015809 |
| 154 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.77877333 |
| 155 | deoxyribonucleotide metabolic process (GO:0009262) | 2.77764921 |
| 156 | peptidyl-histidine modification (GO:0018202) | 2.76261512 |
| 157 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.74885088 |
| 158 | metallo-sulfur cluster assembly (GO:0031163) | 2.73543753 |
| 159 | iron-sulfur cluster assembly (GO:0016226) | 2.73543753 |
| 160 | lipopolysaccharide metabolic process (GO:0008653) | 2.72349128 |
| 161 | DNA replication initiation (GO:0006270) | 2.71134202 |
| 162 | bicarbonate transport (GO:0015701) | 2.68341127 |
| 163 | protein targeting to membrane (GO:0006612) | 2.67405670 |
| 164 | blood coagulation, intrinsic pathway (GO:0007597) | 2.65410001 |
| 165 | plasma lipoprotein particle organization (GO:0071827) | 2.64942682 |
| 166 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.61213723 |
| 167 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.61141007 |
| 168 | lysine metabolic process (GO:0006553) | 2.59073090 |
| 169 | lysine catabolic process (GO:0006554) | 2.59073090 |
| 170 | regulation of response to osmotic stress (GO:0047484) | 2.56014170 |
| 171 | negative regulation of mRNA processing (GO:0050686) | 2.54177176 |
| 172 | histone H3-K4 trimethylation (GO:0080182) | 2.54029654 |
| 173 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.51780926 |
| 174 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.51544195 |
| 175 | response to folic acid (GO:0051593) | 2.50276895 |
| 176 | telomere maintenance via telomere lengthening (GO:0010833) | 2.49989446 |
| 177 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.45306996 |
| 178 | pyrimidine dimer repair (GO:0006290) | 2.44459580 |
| 179 | regulation of DNA endoreduplication (GO:0032875) | 2.44273005 |
| 180 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.43924801 |
| 181 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.40768024 |
| 182 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.37802520 |
| 183 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.36395858 |
| 184 | protein-lipid complex subunit organization (GO:0071825) | 2.35412517 |
| 185 | valine metabolic process (GO:0006573) | 2.32798434 |
| 186 | * protoporphyrinogen IX metabolic process (GO:0046501) | 14.1413812 |
| 187 | * protoporphyrinogen IX biosynthetic process (GO:0006782) | 13.3171223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.04908013 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.80894800 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.41734160 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.88914573 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.88299829 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.57928133 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.38538204 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.10758353 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.00302406 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.95433424 |
| 11 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.83618785 |
| 12 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.78820940 |
| 13 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.68717126 |
| 14 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.65577002 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.64677321 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.63575222 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60258951 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.47018766 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.45113519 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.41019068 |
| 21 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.34098905 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27557276 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23735706 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.20959872 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.13060056 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09632951 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.07788275 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.07150712 |
| 29 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.06824434 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.04867391 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.04859460 |
| 32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.00884489 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96379915 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92762386 |
| 35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.89735535 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88843940 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.88750344 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.88396475 |
| 39 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.87667329 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.87423583 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87345299 |
| 42 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.85092505 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82740292 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.75295747 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.75195655 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74093423 |
| 47 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.72685248 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70707034 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69691698 |
| 50 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66944387 |
| 51 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63463869 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62305426 |
| 53 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.61727255 |
| 54 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.59275627 |
| 55 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58535814 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57836393 |
| 57 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.56643395 |
| 58 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.56641689 |
| 59 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.56081730 |
| 60 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.53644895 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52831900 |
| 62 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.51394962 |
| 63 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.49138949 |
| 64 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.48445418 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47969488 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45496152 |
| 67 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.44710045 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44181390 |
| 69 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42622767 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41885822 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41444739 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39181486 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39135641 |
| 74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38657798 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38346452 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38311466 |
| 77 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37361793 |
| 78 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.36661794 |
| 79 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.36471428 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36270149 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.35159712 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35086376 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34790506 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34692538 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34380319 |
| 86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33253961 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33084604 |
| 88 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33014791 |
| 89 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31914024 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31141451 |
| 91 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31017227 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30229233 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29466800 |
| 94 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28458493 |
| 95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27903602 |
| 96 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.26233377 |
| 97 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24601720 |
| 98 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.22076762 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.21638659 |
| 100 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20581351 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20487708 |
| 102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20018548 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20003264 |
| 104 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17339726 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16826469 |
| 106 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16747056 |
| 107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16410571 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16344308 |
| 109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15979848 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15711527 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 1.14175341 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13019334 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12310851 |
| 114 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12094102 |
| 115 | ERA_21632823_ChIP-Seq_H3396_Human | 1.11698782 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10713533 |
| 117 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10110955 |
| 118 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09554855 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08623075 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08353202 |
| 121 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08193856 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04715066 |
| 123 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.04531946 |
| 124 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04519881 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 1.04161187 |
| 126 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.03551845 |
| 127 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.03411214 |
| 128 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03185539 |
| 129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02279065 |
| 130 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.02144908 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01977788 |
| 132 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01577768 |
| 133 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00735498 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00027394 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98976852 |
| 136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97097096 |
| 137 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96996525 |
| 138 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.96386256 |
| 139 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.96086431 |
| 140 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.95986227 |
| 141 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.95286793 |
| 142 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95118380 |
| 143 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94068077 |
| 144 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93955346 |
| 145 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93770720 |
| 146 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.92189498 |
| 147 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91759586 |
| 148 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90693596 |
| 149 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.90222220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 9.77660077 |
| 2 | MP0004147_increased_porphyrin_level | 7.84363969 |
| 3 | MP0008961_abnormal_basal_metabolism | 3.55922923 |
| 4 | MP0005670_abnormal_white_adipose | 2.94913432 |
| 5 | MP0005083_abnormal_biliary_tract | 2.67641071 |
| 6 | MP0008995_early_reproductive_senescence | 2.52380989 |
| 7 | MP0001545_abnormal_hematopoietic_system | 2.51792911 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 2.51792911 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.37218777 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.28562738 |
| 11 | MP0005636_abnormal_mineral_homeostasis | 2.21887238 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.16040301 |
| 13 | MP0003786_premature_aging | 1.98535841 |
| 14 | MP0000685_abnormal_immune_system | 1.98474479 |
| 15 | MP0002132_abnormal_respiratory_system | 1.94250774 |
| 16 | MP0001502_abnormal_circadian_rhythm | 1.92774535 |
| 17 | MP0010094_abnormal_chromosome_stability | 1.91275042 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 1.90029181 |
| 19 | MP0002398_abnormal_bone_marrow | 1.77056199 |
| 20 | MP0003693_abnormal_embryo_hatching | 1.76873905 |
| 21 | MP0008058_abnormal_DNA_repair | 1.72447074 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.71645579 |
| 23 | MP0000003_abnormal_adipose_tissue | 1.70208175 |
| 24 | MP0003011_delayed_dark_adaptation | 1.69130055 |
| 25 | MP0006054_spinal_hemorrhage | 1.68249470 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.64491779 |
| 27 | MP0002822_catalepsy | 1.63976049 |
| 28 | MP0005365_abnormal_bile_salt | 1.62204140 |
| 29 | MP0005671_abnormal_response_to | 1.56534679 |
| 30 | MP0005360_urolithiasis | 1.55650983 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.55412406 |
| 32 | MP0002722_abnormal_immune_system | 1.53825204 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.53591156 |
| 34 | MP0003123_paternal_imprinting | 1.45965150 |
| 35 | MP0003077_abnormal_cell_cycle | 1.43710493 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.40201459 |
| 37 | MP0002429_abnormal_blood_cell | 1.39540993 |
| 38 | MP0004133_heterotaxia | 1.36068570 |
| 39 | MP0004885_abnormal_endolymph | 1.34142204 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.32583188 |
| 41 | MP0003878_abnormal_ear_physiology | 1.32583188 |
| 42 | MP0008007_abnormal_cellular_replicative | 1.32076004 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.29459420 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.25616007 |
| 45 | MP0000609_abnormal_liver_physiology | 1.23443988 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.19541193 |
| 47 | MP0004742_abnormal_vestibular_system | 1.17917244 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.17515255 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.17452614 |
| 50 | MP0001764_abnormal_homeostasis | 1.17318297 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.17306359 |
| 52 | MP0004043_abnormal_pH_regulation | 1.15743611 |
| 53 | MP0010329_abnormal_lipoprotein_level | 1.15513114 |
| 54 | MP0000490_abnormal_crypts_of | 1.14319725 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.10457807 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.10415985 |
| 57 | MP0003787_abnormal_imprinting | 1.07961480 |
| 58 | MP0005367_renal/urinary_system_phenotyp | 1.07577971 |
| 59 | MP0000516_abnormal_urinary_system | 1.07577971 |
| 60 | MP0005025_abnormal_response_to | 1.07566528 |
| 61 | MP0001968_abnormal_touch/_nociception | 1.07150220 |
| 62 | MP0001984_abnormal_olfaction | 1.06987578 |
| 63 | MP0001790_abnormal_immune_system | 1.06685067 |
| 64 | MP0005387_immune_system_phenotype | 1.06685067 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.06668575 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.06153571 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.05619694 |
| 68 | MP0001529_abnormal_vocalization | 1.05493635 |
| 69 | MP0000716_abnormal_immune_system | 1.05484370 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 1.05482189 |
| 71 | MP0001800_abnormal_humoral_immune | 1.05320384 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.04409635 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.03594010 |
| 74 | MP0003136_yellow_coat_color | 1.01273612 |
| 75 | MP0008872_abnormal_physiological_respon | 1.00954131 |
| 76 | MP0008775_abnormal_heart_ventricle | 0.99998903 |
| 77 | MP0004142_abnormal_muscle_tone | 0.99365608 |
| 78 | MP0001853_heart_inflammation | 0.98299496 |
| 79 | MP0003763_abnormal_thymus_physiology | 0.96740197 |
| 80 | MP0003252_abnormal_bile_duct | 0.96692101 |
| 81 | MP0002420_abnormal_adaptive_immunity | 0.95534920 |
| 82 | MP0003436_decreased_susceptibility_to | 0.95042543 |
| 83 | MP0003121_genomic_imprinting | 0.95041289 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.94385976 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.93661024 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 0.93636019 |
| 87 | MP0001819_abnormal_immune_cell | 0.93111592 |
| 88 | MP0009763_increased_sensitivity_to | 0.92743029 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92685343 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.92473629 |
| 91 | MP0005499_abnormal_olfactory_system | 0.92473629 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.89919730 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.89031917 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.88731239 |
| 95 | MP0000598_abnormal_liver_morphology | 0.88650214 |
| 96 | MP0000372_irregular_coat_pigmentation | 0.88128193 |
| 97 | MP0009931_abnormal_skin_appearance | 0.87474961 |
| 98 | MP0002405_respiratory_system_inflammati | 0.86283431 |
| 99 | MP0002723_abnormal_immune_serum | 0.84824972 |
| 100 | MP0009115_abnormal_fat_cell | 0.84786014 |
| 101 | MP0003186_abnormal_redox_activity | 0.84558268 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.84398737 |
| 103 | MP0000313_abnormal_cell_death | 0.84025320 |
| 104 | MP0008469_abnormal_protein_level | 0.83024632 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.82125723 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.80293860 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.80017042 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.79518742 |
| 109 | MP0009764_decreased_sensitivity_to | 0.79334190 |
| 110 | MP0002736_abnormal_nociception_after | 0.78342223 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77626794 |
| 112 | MP0001905_abnormal_dopamine_level | 0.76172947 |
| 113 | MP0005451_abnormal_body_composition | 0.76030177 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.75040101 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.72254252 |
| 116 | MP0009785_altered_susceptibility_to | 0.72106447 |
| 117 | MP0003718_maternal_effect | 0.71463956 |
| 118 | MP0005501_abnormal_skin_physiology | 0.71313349 |
| 119 | MP0002419_abnormal_innate_immunity | 0.71054683 |
| 120 | MP0003724_increased_susceptibility_to | 0.70620648 |
| 121 | MP0001929_abnormal_gametogenesis | 0.69721439 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.69466184 |
| 123 | MP0003698_abnormal_male_reproductive | 0.69463278 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.69442761 |
| 125 | MP0009278_abnormal_bone_marrow | 0.68299597 |
| 126 | MP0008770_decreased_survivor_rate | 0.68048357 |
| 127 | MP0002970_abnormal_white_adipose | 0.67520650 |
| 128 | MP0009046_muscle_twitch | 0.67451944 |
| 129 | MP0002928_abnormal_bile_duct | 0.66507489 |
| 130 | MP0001663_abnormal_digestive_system | 0.66472092 |
| 131 | MP0000955_abnormal_spinal_cord | 0.65600824 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.65215823 |
| 133 | MP0003866_abnormal_defecation | 0.64942499 |
| 134 | MP0002160_abnormal_reproductive_system | 0.64915613 |
| 135 | MP0002653_abnormal_ependyma_morphology | 0.64847181 |
| 136 | MP0004145_abnormal_muscle_electrophysio | 0.64444033 |
| 137 | MP0002277_abnormal_respiratory_mucosa | 0.63711204 |
| 138 | MP0002735_abnormal_chemical_nociception | 0.63270695 |
| 139 | MP0002135_abnormal_kidney_morphology | 0.61063438 |
| 140 | MP0009840_abnormal_foam_cell | 0.59786994 |
| 141 | MP0009379_abnormal_foot_pigmentation | 0.59451322 |
| 142 | MP0005266_abnormal_metabolism | 0.59336677 |
| 143 | MP0003868_abnormal_feces_composition | 0.58924470 |
| 144 | MP0000015_abnormal_ear_pigmentation | 0.58037492 |
| 145 | MP0001986_abnormal_taste_sensitivity | 0.58036032 |
| 146 | MP0003172_abnormal_lysosome_physiology | 0.57961874 |
| 147 | MP0001845_abnormal_inflammatory_respons | 0.57786167 |
| 148 | MP0005253_abnormal_eye_physiology | 0.55904634 |
| 149 | MP0008873_increased_physiological_sensi | 0.55766231 |
| 150 | MP0002210_abnormal_sex_determination | 0.55326360 |
| 151 | MP0001324_abnormal_eye_pigmentation | 0.54298150 |
| 152 | MP0008057_abnormal_DNA_replication | 0.53971631 |
| 153 | MP0005334_abnormal_fat_pad | 0.53828193 |
| 154 | MP0003567_abnormal_fetal_cardiomyocyte | 0.53652208 |
| 155 | MP0003195_calcinosis | 0.51975028 |
| 156 | MP0002272_abnormal_nervous_system | 0.49308310 |
| 157 | MP0001270_distended_abdomen | 0.49227091 |
| 158 | MP0005423_abnormal_somatic_nervous | 0.49068146 |
| 159 | MP0001145_abnormal_male_reproductive | 0.48568985 |
| 160 | MP0005448_abnormal_energy_balance | 0.48314662 |
| 161 | MP0002136_abnormal_kidney_physiology | 0.48250294 |
| 162 | MP0002229_neurodegeneration | 0.47235108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 9.33433054 |
| 2 | Acanthocytosis (HP:0001927) | 6.72868519 |
| 3 | Reticulocytosis (HP:0001923) | 6.72810095 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 6.46522883 |
| 5 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.05435059 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.00123821 |
| 7 | Hyperbilirubinemia (HP:0002904) | 5.71002639 |
| 8 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.55855523 |
| 9 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.55855523 |
| 10 | Hypochromic microcytic anemia (HP:0004840) | 5.50916308 |
| 11 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.33980380 |
| 12 | Abnormality of reticulocytes (HP:0004312) | 5.28974205 |
| 13 | Abnormal ciliary motility (HP:0012262) | 5.21155554 |
| 14 | Absent/shortened dynein arms (HP:0200106) | 5.03837310 |
| 15 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.03837310 |
| 16 | Rhinitis (HP:0012384) | 4.57656224 |
| 17 | Cholelithiasis (HP:0001081) | 4.44474372 |
| 18 | Paralysis (HP:0003470) | 4.36462628 |
| 19 | Diaphragmatic weakness (HP:0009113) | 4.23257538 |
| 20 | Abnormal gallbladder morphology (HP:0012437) | 4.17437246 |
| 21 | Insomnia (HP:0100785) | 3.74514838 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.72683243 |
| 23 | Chronic bronchitis (HP:0004469) | 3.72261830 |
| 24 | Osteomalacia (HP:0002749) | 3.69458114 |
| 25 | Abnormality of the prostate (HP:0008775) | 3.53099520 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 3.48222408 |
| 27 | Petechiae (HP:0000967) | 3.44559153 |
| 28 | Prolonged bleeding time (HP:0003010) | 3.43232008 |
| 29 | * Cutaneous photosensitivity (HP:0000992) | 3.36612694 |
| 30 | Tubulointerstitial nephritis (HP:0001970) | 3.31419953 |
| 31 | Hypochromic anemia (HP:0001931) | 3.23577261 |
| 32 | Bronchiectasis (HP:0002110) | 3.22352374 |
| 33 | Pancreatic fibrosis (HP:0100732) | 3.21202645 |
| 34 | Macrocytic anemia (HP:0001972) | 3.19152492 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 3.07938348 |
| 36 | Pallor (HP:0000980) | 3.07278515 |
| 37 | Abnormality of the gallbladder (HP:0005264) | 3.03460700 |
| 38 | Microcytic anemia (HP:0001935) | 3.02702542 |
| 39 | Pancreatic cysts (HP:0001737) | 3.00337922 |
| 40 | Abnormality of the renal medulla (HP:0100957) | 2.89931255 |
| 41 | Nasal polyposis (HP:0100582) | 2.88970536 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.88744245 |
| 43 | Molar tooth sign on MRI (HP:0002419) | 2.88744245 |
| 44 | True hermaphroditism (HP:0010459) | 2.85489590 |
| 45 | Polycythemia (HP:0001901) | 2.84816944 |
| 46 | Epistaxis (HP:0000421) | 2.84632111 |
| 47 | Occipital encephalocele (HP:0002085) | 2.82817210 |
| 48 | Nephronophthisis (HP:0000090) | 2.80549503 |
| 49 | Reticulocytopenia (HP:0001896) | 2.73265955 |
| 50 | Cystic liver disease (HP:0006706) | 2.72113553 |
| 51 | Increased serum ferritin (HP:0003281) | 2.70472690 |
| 52 | Progressive microcephaly (HP:0000253) | 2.67440409 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.67097188 |
| 54 | Cholecystitis (HP:0001082) | 2.67097188 |
| 55 | Renal salt wasting (HP:0000127) | 2.58315815 |
| 56 | Type II lissencephaly (HP:0007260) | 2.57931159 |
| 57 | Tubulointerstitial abnormality (HP:0001969) | 2.57298221 |
| 58 | Hypokalemic alkalosis (HP:0001949) | 2.55202223 |
| 59 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.54513733 |
| 60 | Congenital hepatic fibrosis (HP:0002612) | 2.51675675 |
| 61 | Cerebral palsy (HP:0100021) | 2.50986021 |
| 62 | Abnormality of the renal cortex (HP:0011035) | 2.49749515 |
| 63 | Gait imbalance (HP:0002141) | 2.42969372 |
| 64 | Abnormality of chloride homeostasis (HP:0011422) | 2.42808129 |
| 65 | Absent speech (HP:0001344) | 2.41510646 |
| 66 | Exertional dyspnea (HP:0002875) | 2.40429162 |
| 67 | Protruding tongue (HP:0010808) | 2.40153923 |
| 68 | Retinal dysplasia (HP:0007973) | 2.39035563 |
| 69 | Hepatocellular necrosis (HP:0001404) | 2.36942483 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.36785424 |
| 71 | Hepatic necrosis (HP:0002605) | 2.33789193 |
| 72 | Congenital primary aphakia (HP:0007707) | 2.32738637 |
| 73 | Purpura (HP:0000979) | 2.32708991 |
| 74 | Abnormality of the nasal mucosa (HP:0000433) | 2.31991696 |
| 75 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31615302 |
| 76 | Hyponatremia (HP:0002902) | 2.31447514 |
| 77 | Postaxial foot polydactyly (HP:0001830) | 2.28992464 |
| 78 | Nonimmune hydrops fetalis (HP:0001790) | 2.27376397 |
| 79 | Prolonged partial thromboplastin time (HP:0003645) | 2.22892128 |
| 80 | Aplastic anemia (HP:0001915) | 2.21840122 |
| 81 | Ileus (HP:0002595) | 2.21720594 |
| 82 | Lissencephaly (HP:0001339) | 2.21531049 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.21258358 |
| 84 | Tubular atrophy (HP:0000092) | 2.19929749 |
| 85 | Abnormality of renal resorption (HP:0011038) | 2.19459895 |
| 86 | Chronic otitis media (HP:0000389) | 2.19308979 |
| 87 | Renal tubular acidosis (HP:0001947) | 2.18465160 |
| 88 | Respiratory difficulties (HP:0002880) | 2.14871285 |
| 89 | Anencephaly (HP:0002323) | 2.13552725 |
| 90 | Abnormality of male internal genitalia (HP:0000022) | 2.12860657 |
| 91 | Asplenia (HP:0001746) | 2.11015179 |
| 92 | Hyperglycinemia (HP:0002154) | 2.10972308 |
| 93 | Abnormal platelet function (HP:0011869) | 2.10010452 |
| 94 | Impaired platelet aggregation (HP:0003540) | 2.10010452 |
| 95 | Tubulointerstitial fibrosis (HP:0005576) | 2.09837580 |
| 96 | Seborrheic dermatitis (HP:0001051) | 2.09404259 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09120325 |
| 98 | Obstructive lung disease (HP:0006536) | 2.09120325 |
| 99 | Chest pain (HP:0100749) | 2.09086791 |
| 100 | Increased CSF lactate (HP:0002490) | 2.08852225 |
| 101 | Microvesicular hepatic steatosis (HP:0001414) | 2.08799876 |
| 102 | Urticaria (HP:0001025) | 2.08372542 |
| 103 | Sclerocornea (HP:0000647) | 2.08363297 |
| 104 | Generalized aminoaciduria (HP:0002909) | 2.07047348 |
| 105 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.04879390 |
| 106 | Polyuria (HP:0000103) | 2.02543308 |
| 107 | Chronic sinusitis (HP:0011109) | 2.02186720 |
| 108 | Nausea (HP:0002018) | 2.01305713 |
| 109 | Neoplasm of the adrenal cortex (HP:0100641) | 2.00380227 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00275601 |
| 111 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 13.1716291 |
| 112 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99881826 |
| 113 | Abnormality of sodium homeostasis (HP:0010931) | 1.99359024 |
| 114 | Hyperaldosteronism (HP:0000859) | 1.96466614 |
| 115 | Decreased central vision (HP:0007663) | 1.93781156 |
| 116 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92382429 |
| 117 | Infertility (HP:0000789) | 1.92136881 |
| 118 | Thrombocytosis (HP:0001894) | 1.91983998 |
| 119 | Type I transferrin isoform profile (HP:0003642) | 1.91259106 |
| 120 | Colon cancer (HP:0003003) | 1.89688134 |
| 121 | Hepatocellular carcinoma (HP:0001402) | 1.89350099 |
| 122 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88346529 |
| 123 | Panhypogammaglobulinemia (HP:0003139) | 1.86721899 |
| 124 | Renal tubular dysfunction (HP:0000124) | 1.85916617 |
| 125 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.84079696 |
| 126 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83746372 |
| 127 | Birth length less than 3rd percentile (HP:0003561) | 1.82290773 |
| 128 | Bronchitis (HP:0012387) | 1.82130666 |
| 129 | Porencephaly (HP:0002132) | 1.80854065 |
| 130 | Hypertensive crisis (HP:0100735) | 1.79490056 |
| 131 | Menorrhagia (HP:0000132) | 1.79477658 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78175207 |
| 133 | Brushfield spots (HP:0001088) | 1.77584970 |
| 134 | Joint hemorrhage (HP:0005261) | 1.77501809 |
| 135 | Metabolic alkalosis (HP:0200114) | 1.77438287 |
| 136 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77403491 |
| 137 | Confusion (HP:0001289) | 1.77157977 |
| 138 | Hypoglycemic coma (HP:0001325) | 1.77053670 |
| 139 | Exercise intolerance (HP:0003546) | 1.76911110 |
| 140 | Broad distal phalanx of finger (HP:0009836) | 1.75736738 |
| 141 | Vaginal atresia (HP:0000148) | 1.75618312 |
| 142 | Ureteral stenosis (HP:0000071) | 1.75467574 |
| 143 | Broad palm (HP:0001169) | 1.75166350 |
| 144 | Mitochondrial inheritance (HP:0001427) | 1.75158274 |
| 145 | Acute lymphatic leukemia (HP:0006721) | 1.73416551 |
| 146 | Severe global developmental delay (HP:0011344) | 1.73360305 |
| 147 | Increased serum lactate (HP:0002151) | 1.71323576 |
| 148 | Pathologic fracture (HP:0002756) | 1.70347818 |
| 149 | Retinitis pigmentosa (HP:0000510) | 1.69187975 |
| 150 | Poor coordination (HP:0002370) | 1.68199014 |
| 151 | Metabolic acidosis (HP:0001942) | 1.67553746 |
| 152 | Hypertriglyceridemia (HP:0002155) | 1.64042507 |
| 153 | IgM deficiency (HP:0002850) | 1.60846606 |
| 154 | Pustule (HP:0200039) | 1.60839807 |
| 155 | Limb hypertonia (HP:0002509) | 1.59824252 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.59410632 |
| 157 | Reduced antithrombin III activity (HP:0001976) | 1.59188276 |
| 158 | Abnormality of the fingertips (HP:0001211) | 1.58501398 |
| 159 | Increased intramyocellular lipid droplets (HP:0012240) | 1.58119619 |
| 160 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.57520248 |
| 161 | Thrombophlebitis (HP:0004418) | 1.56419723 |
| 162 | Global brain atrophy (HP:0002283) | 1.56137399 |
| 163 | Increased muscle lipid content (HP:0009058) | 1.54659913 |
| 164 | Hyperacusis (HP:0010780) | 1.53129384 |
| 165 | Esophageal neoplasm (HP:0100751) | 1.52975358 |
| 166 | Neoplasm of head and neck (HP:0012288) | 1.52975358 |
| 167 | Recurrent sinusitis (HP:0011108) | 1.52712986 |
| 168 | Onycholysis (HP:0001806) | 1.51932401 |
| 169 | Neutropenia (HP:0001875) | 1.51713210 |
| 170 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.51439924 |
| 171 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.51439924 |
| 172 | Broad face (HP:0000283) | 1.50942872 |
| 173 | Hypercholesterolemia (HP:0003124) | 1.50696389 |
| 174 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.50352059 |
| 175 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.50352059 |
| 176 | Short middle phalanx of the 5th finger (HP:0004220) | 1.49406683 |
| 177 | Conjugated hyperbilirubinemia (HP:0002908) | 1.48745518 |
| 178 | Colitis (HP:0002583) | 1.47483798 |
| 179 | Oral leukoplakia (HP:0002745) | 1.47240811 |
| 180 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.46744172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.38002983 |
| 2 | TLK1 | 4.25941666 |
| 3 | CAMKK2 | 4.17396052 |
| 4 | CAMK1D | 3.34493178 |
| 5 | SMG1 | 3.02504802 |
| 6 | EIF2AK1 | 3.00971700 |
| 7 | VRK1 | 2.97463926 |
| 8 | NME2 | 2.71512703 |
| 9 | TAF1 | 2.56767456 |
| 10 | EEF2K | 2.56075705 |
| 11 | MAP4K1 | 2.39955261 |
| 12 | STK16 | 2.22909490 |
| 13 | DYRK3 | 2.19978101 |
| 14 | MAP3K10 | 2.08693740 |
| 15 | MAPK15 | 1.99802207 |
| 16 | CAMK1G | 1.98694639 |
| 17 | TAOK3 | 1.97425354 |
| 18 | WNK4 | 1.96580147 |
| 19 | NUAK1 | 1.89150537 |
| 20 | MAP3K7 | 1.84892720 |
| 21 | BCKDK | 1.81147926 |
| 22 | PRPF4B | 1.73364797 |
| 23 | FLT3 | 1.71940520 |
| 24 | MAP4K2 | 1.70746823 |
| 25 | STK10 | 1.68308513 |
| 26 | MAPK11 | 1.62500785 |
| 27 | BRSK1 | 1.59718244 |
| 28 | CAMKK1 | 1.57520794 |
| 29 | BTK | 1.56766206 |
| 30 | TGFBR2 | 1.56028714 |
| 31 | SYK | 1.55240699 |
| 32 | MAPKAPK5 | 1.48934367 |
| 33 | ERN1 | 1.46093188 |
| 34 | DYRK2 | 1.36844506 |
| 35 | SIK1 | 1.35012197 |
| 36 | KIT | 1.33767873 |
| 37 | SIK2 | 1.30946560 |
| 38 | GRK6 | 1.30600231 |
| 39 | STK4 | 1.30076105 |
| 40 | MAPKAPK3 | 1.29279211 |
| 41 | TYK2 | 1.28662462 |
| 42 | CHUK | 1.19964139 |
| 43 | IRAK4 | 1.19447631 |
| 44 | MAP3K11 | 1.14548122 |
| 45 | BRD4 | 1.13307052 |
| 46 | TESK1 | 1.12984089 |
| 47 | SRPK1 | 1.12728272 |
| 48 | NEK2 | 1.12500167 |
| 49 | BUB1 | 1.12261399 |
| 50 | TNIK | 1.11663240 |
| 51 | MARK2 | 1.11142988 |
| 52 | CDC7 | 1.10292050 |
| 53 | CAMK1 | 1.10178876 |
| 54 | CDK19 | 1.03898530 |
| 55 | LYN | 1.02650381 |
| 56 | WEE1 | 1.01181828 |
| 57 | BRSK2 | 0.93570819 |
| 58 | IRAK3 | 0.93453426 |
| 59 | GRK5 | 0.90458793 |
| 60 | RPS6KA5 | 0.88581074 |
| 61 | CSF1R | 0.87022100 |
| 62 | JAK3 | 0.86860604 |
| 63 | TBK1 | 0.85619805 |
| 64 | JAK2 | 0.84461150 |
| 65 | TEC | 0.83821928 |
| 66 | MAP3K4 | 0.81619162 |
| 67 | CLK1 | 0.80392548 |
| 68 | TAOK2 | 0.80059473 |
| 69 | MAPK13 | 0.79002674 |
| 70 | BLK | 0.78850012 |
| 71 | CDC42BPA | 0.78659209 |
| 72 | ZAP70 | 0.78030142 |
| 73 | TIE1 | 0.76821781 |
| 74 | PIM1 | 0.76233712 |
| 75 | DYRK1B | 0.74667497 |
| 76 | IKBKB | 0.74051039 |
| 77 | CSNK1G3 | 0.73960446 |
| 78 | MAP2K3 | 0.73812822 |
| 79 | YES1 | 0.73789323 |
| 80 | MKNK2 | 0.73190108 |
| 81 | ATR | 0.72949501 |
| 82 | CDK4 | 0.72044436 |
| 83 | IKBKE | 0.71189279 |
| 84 | PIM2 | 0.70871548 |
| 85 | HIPK2 | 0.68536395 |
| 86 | AURKB | 0.68016023 |
| 87 | TESK2 | 0.67671625 |
| 88 | LRRK2 | 0.67597928 |
| 89 | KDR | 0.66818690 |
| 90 | INSRR | 0.66767261 |
| 91 | CCNB1 | 0.66663786 |
| 92 | AURKA | 0.66568939 |
| 93 | ITK | 0.66095604 |
| 94 | LCK | 0.63839003 |
| 95 | RPS6KL1 | 0.63686648 |
| 96 | RPS6KC1 | 0.63686648 |
| 97 | BRAF | 0.63367618 |
| 98 | RPS6KB2 | 0.63354207 |
| 99 | RPS6KA6 | 0.62531587 |
| 100 | MAPK12 | 0.62113671 |
| 101 | CDK7 | 0.60506068 |
| 102 | GRK7 | 0.58488494 |
| 103 | MAP2K2 | 0.57952484 |
| 104 | CSNK1A1L | 0.57423827 |
| 105 | RPS6KA2 | 0.55231077 |
| 106 | FES | 0.54724970 |
| 107 | ABL2 | 0.53192577 |
| 108 | CSNK1G2 | 0.52544462 |
| 109 | MAP2K7 | 0.52349201 |
| 110 | TXK | 0.51440988 |
| 111 | MAPKAPK2 | 0.50751876 |
| 112 | CHEK2 | 0.50072867 |
| 113 | NME1 | 0.49938757 |
| 114 | ACVR1B | 0.49265626 |
| 115 | CASK | 0.48442424 |
| 116 | PRKAA2 | 0.48373026 |
| 117 | ZAK | 0.47507024 |
| 118 | CDK8 | 0.44180993 |
| 119 | ERBB2 | 0.44031889 |
| 120 | TRIB3 | 0.43966755 |
| 121 | TRPM7 | 0.42648403 |
| 122 | MAP3K8 | 0.42059344 |
| 123 | UHMK1 | 0.42044584 |
| 124 | TNK2 | 0.41442842 |
| 125 | ATM | 0.40222416 |
| 126 | DAPK1 | 0.39761756 |
| 127 | GRK1 | 0.39277479 |
| 128 | MAPK3 | 0.38620936 |
| 129 | CAMK4 | 0.36775439 |
| 130 | PKN2 | 0.36733123 |
| 131 | CSNK1G1 | 0.35717665 |
| 132 | PRKCQ | 0.35352043 |
| 133 | CDK9 | 0.35331164 |
| 134 | PRKCI | 0.33757802 |
| 135 | MKNK1 | 0.33651374 |
| 136 | DYRK1A | 0.32332775 |
| 137 | LIMK1 | 0.32160714 |
| 138 | MAPK4 | 0.30115130 |
| 139 | ICK | 0.28608619 |
| 140 | CSK | 0.28560649 |
| 141 | PKN1 | 0.21368229 |
| 142 | MAPK9 | 0.17773999 |
| 143 | PTK2B | 0.16843207 |
| 144 | PRKCA | 0.16774999 |
| 145 | MARK3 | 0.16431828 |
| 146 | PRKAA1 | 0.16125316 |
| 147 | ADRBK2 | 0.15238613 |
| 148 | PRKCD | 0.14908794 |
| 149 | WNK1 | 0.14180429 |
| 150 | PRKACA | 0.13211409 |
| 151 | CSNK2A1 | 0.13073099 |
| 152 | PINK1 | 0.12953731 |
| 153 | DAPK3 | 0.12340188 |
| 154 | PRKD1 | 0.12195190 |
| 155 | WNK3 | 0.10311242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 5.79819035 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.92512822 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.77475654 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 3.56696236 |
| 5 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 3.03516595 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.73950768 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.70801160 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.51635080 |
| 9 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.41230331 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.21797666 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 2.10029923 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.92170368 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91547935 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.90739833 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.86789067 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.82124298 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.78891391 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.71617221 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70853488 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.69176005 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68077506 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62022791 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57737811 |
| 24 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.56749094 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52371784 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49153997 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47211814 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44421118 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42242115 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.41236247 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37941210 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37636640 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.34647353 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.31748169 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.30382659 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.28195559 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27796526 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.25627281 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22519716 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22080338 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20278230 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19723568 |
| 43 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.14312104 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12935915 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.11521878 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04431781 |
| 47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04208892 |
| 48 | Alcoholism_Homo sapiens_hsa05034 | 0.98873280 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97661550 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97368190 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96768003 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94937995 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94210574 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93064001 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87831325 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86336943 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.86168081 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85437561 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82760923 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79306479 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79036971 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78121695 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77572795 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76812932 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72210591 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71788422 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71252029 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71087570 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70247232 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68101062 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68087791 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.67115408 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66112867 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65064369 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.64901218 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64356179 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62042622 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60824850 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60597724 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60535705 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58913803 |
| 82 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57557414 |
| 83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56927858 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.56885531 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56784740 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.55561002 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54860344 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53076191 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52355843 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52231117 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52006198 |
| 92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.51913801 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51570349 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51379316 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.50560190 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50248023 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49536086 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48108024 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.47864962 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47339395 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.46179016 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45548941 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44895089 |
| 104 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44483694 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43542966 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43374215 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42944128 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42028378 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41701611 |
| 110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41647972 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.41382051 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41344821 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40161689 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39847582 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39771836 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39449319 |
| 117 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38771743 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38446394 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37959601 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37383589 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.36666112 |
| 122 | Proteasome_Homo sapiens_hsa03050 | 0.34831956 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32750338 |
| 124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32376184 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31805623 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30183756 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29070569 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28748147 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28622875 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28489872 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28396498 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28279373 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.26588619 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24764330 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.24530102 |
| 136 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.24513114 |
| 137 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23362743 |
| 138 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23277447 |
| 139 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.22654748 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22139445 |
| 141 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21760063 |

